Supporting the relevance of inflammasome activation in dysferlinopathy, previous studies have shown increased levels of NLRP3, ASC, active caspase-1, and mature IL-1β in skeletal muscles from dysferlin-deficient (A/J) mice [36]. Here, DYSF is linked to neuromuscular disease caused by qualitative or quantitative defects of dysferlin.